Últimas noticias sobre Banco Macro (NYSE:BMA) Bolsa

Banco Macro

Banco Macro SA is a financial institution and it provides standard banking products and services designed to suit individual needs. It has two categories of customers, retail customers, which include individuals and entrepreneurs, and corporate customers, which include small, medium, and large companies and corporations. In addition, it provides services to four provincial governments. It generates the majority of its revenue from Argentina.

Banco Macro S.A. ADR (representing Ten Class B Common Shares)

Banco Macro SA

BLACK MTN ACQUISITION CORP COM CL A

Innovator U.S. Equity Buffer ETF - March

Innovator U.S. Equity Buffer ETF - May

WIIM

BBAR

BBVA

BSBR

ITUB

Shares of US banks are trading higher after Federal Reserve Board Vice Chair for Supervision Michael Barr announced he will step down, effective Feb. 28.

BANR

CVBF

EWBC

FITB

GGAL

HBAN

INTR

Shares of banking companies are trading lower amid overall market sympathy following the Fed's rate decision to cut rates by 25 basis points.

Banco Macro shares are trading higher after Morgan Stanley upgraded the stock from Underweight to Overweight.

Morgan Stanley analyst Jorge Kuri upgrades Banco Macro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMA#NYSE">BMA</a>) from Underweight to Overweight and announces $12.5 price target.

News

Upgrades

Price Target

Analyst Ratings

Morgan Stanley Upgrades Banco Macro to Overweight, Announces $12.5 Price Target

Earnings

Banco Macro Q3 Net Income Up 293% YoY, Total Deposits Increase 30% YoY

ARGT

CEPU

CRESY

LOMA

MELI

SUPV

Telecom Argentina Stet - France Telecom S.A.

Shares of US-listed Argentine stocks are trading higher on continued strength after the nation received a credit upgrade from Fitch over the weekend.

DESP

Shares of US-listed Argentine stocks are trading higher after Donald Trump's presidential victory.

BIOX

Shares of US-listed Argentine stocks are trading higher after Banco de la Nacion, the country's largest bank, stated it wants to issue debt and return to international capital markets for the first time in 30 years.

U.S. stocks were higher, with the Nasdaq Composite gaining around 150 points on Friday.
Shares of Marvell Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) rose during Friday's session after the company reported <a href="https://www.benzinga.com/news/earnings/24/08/40639373/marvell-technology-stock-climbs-on-q2-strong-q3-guidance">better-than-expected quarterly sales results.</a>
Marvell reported quarterly GAAP earnings of 30 cents per share, in-line with the analyst consensus estimate. Quarterly sales came in at $1.27 billion, which beat the analyst consensus estimate by 1.65%.
Marvell Technology shares gained 6.1% to $74.09 on Friday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Leslie&#8217;s, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LESL#NASDAQ">LESL</a>) shares jumped 18.2% to $2.9552.</li>
<li>MongoDB, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) gained 15.8% to $284.62 after the company reported better-than-expected second-quarter financial results and issued strong guidance on Thursday.</li>
<li>Intuitive Machines, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>) jumped 15.3% to $5.56 after the company was awarded a $116.9 million NASA contract to deliver six science and technology payloads to the Moon.</li>
<li>Polestar Automotive Holding UK PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSNY#NASDAQ">PSNY</a>) gained 10.7% to $1.1850. Cantor Fitzgerald analyst Andres Sheppard reiterated Polestar Automotive with an Overweight and maintained a $3 price target.</li>
<li>BridgeBio Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBIO#NASDAQ">BBIO</a>) gained 10.1% to $27.09 in reaction to Alnylam Pharmaceuticals&#8217; detailed data from HELIOS-B Phase 3 study of vutrisiran. BridgeBio Pharma has ATTR-CM therapy acoramidis, currently under FDA priority review with an action date of November 29.</li>
<li>Cool Company Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLCO#NYSE">CLCO</a>) rose 9.6% to $12.06. Cool Co recently reported better-than-expected quarterly sales.</li>
<li>ZEEKR Intelligent Technology Holding Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZK#NYSE">ZK</a>) gained 8.3% to $17.54.</li>
<li>Highest Performances Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HPH#NASDAQ">HPH</a>) rose 7.9% to $1.9638.</li>
<li>Titan Machinery Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TITN#NASDAQ">TITN</a>) gained 7.9% to $15.36.</li>
<li>Intel Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) rose 7.8% to $21.70 following a report suggesting the company is weighing options including splitting its product design and manufacturing businesses.</li>
<li>Banco Macro S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMA#NYSE">BMA</a>) gained 7.8% to $60.07. JP Morgan analyst Domingos Falavina upgraded Banco Macro from Underweight to Neutral and raised the price target from $14 to $78.</li>
<li>MINISO Group Holding Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MNSO#NYSE">MNSO</a>) gained 5.5% to $17.23 after the company reported fourth-quarter financial results and announced a share repurchase program of HK$2 billion.</li>
<li>Frontline plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FRO#NYSE">FRO</a>) gained 4.6% to $24.41 following strong quarterly sales.</li>
<li>Autodesk, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) rose 4% to $268.33 as the company posted better-than-expected second-quarter EPS and revenues on Thursday.</li>
<li>CrowdStrike Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) gained 4% to $282.45. HSBC analyst Stephen Bersey upgraded CrowdStrike from Hold to Buy and raised the price target from $302 to $339.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40651658/this-is-a-very-speculative-situation-jim-cramer-on-adma-biologics">&#8216;This Is A Very Speculative Situation,&#8217; Jim Cramer On ADMA Biologics</a></li>
</ul>

Intraday Update

Markets

Movers

Trading Ideas

ADSK

BBIO

CLCO

CRWD

INTC

LESL

LUNR

MNSO

MRVL

PSNY

TITN

Marvell Technology Posts Upbeat Sales, Joins MongoDB, Intel, MINISO Group And Other Big Stocks Moving Higher On Friday

Banco Marco shares are trading higher after JP Morgan upgraded the stock from Underweight to Neutral and raised its price target from $14 to $78.

JP Morgan analyst Domingos Falavina upgrades Banco Macro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMA#NYSE">BMA</a>) from Underweight to Neutral and raises the price target from $14 to $78.

JP Morgan Upgrades Banco Macro to Neutral, Raises Price Target to $78

Banco Marco shares are trading higher. The company reported Q2 financial results.

Banco Macro Q2 Net Income Ps.233.2B Loss; Net Interest Income Ps.188B Down From Ps.213.1B YoY

Banco Macro shares are trading higher after B of A Securities upgraded the stock from Underperform to Neutral and raised its price target from $53 to $62.

B of A Securities analyst Ernesto Gabilondo upgrades Banco Macro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMA#NYSE">BMA</a>) from Underperform to Neutral and raises the price target from $53 to $62.

B of A Securities Upgrades Banco Macro to Neutral, Raises Price Target to $62

CADE

FCNCA

FMAO

IBTX

INDB

PPBI

TCBI

WSFS

WTFC

Shares of banking companies are trading lower amid overall market weakness on US economic concerns.

HMNF

HSBC

MUFG

VBFC

Shares of banking companies are trading lower amid overall market weakness following weak US jobs data.

Shares of US-listed Argentina stocks are trading higher after Argentina's Senate passed the Bases law.

Deutsche Bank AG (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/db#NYSE">DB</a>) benefits from a strong balance sheet position and revenue growth. Its strong liquidity profile aids sustainable capital distribution activities. However, a rise in expenses and a deterioration in credit quality are concerning.
Deutsche Bank continues to benefit from its deposit balance. The metric has witnessed a 2% CAGR over the last five years (ending in 2023) and the trend continued in the first quarter of 2024. Furthermore, the bank benefits from a diverse deposit base that spans multiple client categories and geographic regions. Also, as of Mar 31, 2024, the company&#39;s loan-to-deposit ratio was 75.7%, indicating a robust and steady capital foundation. We believe that a stable deposit level will benefit its balance sheet.
DB remains focused on strengthening its capital position. As of Mar 31, 2024, the Common Equity Tier 1 (CET 1) ratio was 13.4%. Risk-weighted asset (RWA) reductions and strong organic capital generation enabled the bank to see improvement in the CET1 ratio. As of Mar 31, 2024, &euro;15 billion of RWA reductions have been achieved, out of the target to reach &euro;25-30 billion in reductions by 2025-end. It expects to maintain a CET 1 ratio of approximately 13% by 2025.
Net revenues recorded a CAGR of 2.7% over the last five years (ended 2023), with this upswing persisting in the first quarter of 2024. Management is shifting focus from investment banking to more stable and capital-light businesses, like private bank, corporate bank and asset management units.
Shares of this Zacks Rank #3 (Hold) company have gained 20% on the NYSE over the past three months compared with the industry&#39;s growth of 10.8%.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/4e/68122.jpg?v=1559669298" />
Image Source: Zacks Investment Research
The bank has seen a deterioration in its credit quality. Its provision for credit losses witnessed a CAGR of 23.4% over the last five years (ended 2023), with the rising trend continuing in the first quarter of 2024. The current volatile economic backdrop is expected to affect credit quality in the near term. We project provisions to be &euro;1.67 billion and &euro;3.91 billion in 2024 and 2025, respectively.
Due to the nature of its business, Deutsche Bank is involved in litigation, arbitration and regulatory processes in Germany as well as a number of other jurisdictions. The bank has already incurred considerable legal settlement fees, which have had a negative impact on its finances.
<h3>Bank Stocks Worth Considering</h3>
Some better-ranked foreign bank stocks are Banco Macro S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bma#NYSE">BMA</a>) and Bancolombia S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cib#NYSE">CIB</a>).
The consensus estimate for Banco Macro&#39;s current-year earnings has been revised 29.6% upward over the past 30 days. Over the past three months, shares of BMA have surged 69.9%. The stock currently sports a Zacks Rank #1 (Strong Buy).
Bancolombia S.A.&#39;s current-year earnings have been revised almost 1% upward over the past 30 days. Shares of CIB have gained 11.6% over the past three months. The stock currently carries a Zacks Rank #2 (Buy).
<a href="https://www.zacks.com/stock/news/2283456/deutsche-bank-s-db-deposit-base-aids-low-credit-quality-ails?cid=CS-BENZ-FT-analyst_blog|zer_report_update-2283456">To read this article on Zacks.com click here.</a>

Deutsche Bank's Deposit Base Aids, Low Credit Quality Ails

Ita&uacute; Unibanco Holding S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/itub#NYSE">ITUB</a>) has announced a corporate internal restructuring plan. This will include the merger of its wholly-owned subsidiary, Hipercard Banco M&uacute;ltiplo S.A. (&quot;Hipercard&quot;), subject to approval from the Central Bank of Brazil. The cost associated with executing and implementing the transaction is estimated to be approximately R$180,000 ($34,843). 
As part of the effort, all activities currently managed by Hipercard, including the administration of bank cards, will be transferred to Ita&uacute; Unibanco. The primary purpose of this merger is to achieve greater synergy among the companies and activities of the ITUB conglomerate. This will help streamline costs and enhance efficiency. 
Following the completion of the transaction, Hipercard will be dissolved as an entity and its assets will be taken over by ITUB. This will lead to a reduction in maintenance costs, rationalization in administrative and commercial activities and an improvement in the overall corporate structure. 
Ita&uacute; Unibanco will take over Hipercard&#39;s equity worth R$2.68 billion ($518 million). The merger will not result in any increase in capital or the issuance of new shares of ITUB. There will be no exchange ratio. Also, rules relating to withdrawal rights for dissenting shareholders will not apply. Overall, the transaction will not have any financial impact on Ita&uacute; Unibanco. 
This strategic move highlights ITUB&#39;s ability to adapt to the trends of the rapidly evolving market and strengthen its competitive placement. Through such efforts, the company is well-poised to improve its market leadership and drive sustainable growth in the long run.
Over the past six months, the company&#39;s shares on the NYSE have lost 3.1% against the industry&#39;s growth of 14.4%. 
&nbsp;&nbsp;<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/9d/67596.jpg?v=56193037" /> 
Image Source -&nbsp;Zacks Investment Research
At present, ITUB carries a Zacks Rank #3 (Hold).
<h3>Stocks to Consider</h3>
Some better-ranked foreign finance stocks are Bancolombia S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cib#NYSE">CIB</a>) and Banco Macro S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bma#NYSE">BMA</a>). 
Bancolombia S.A.&#39;s current-year earnings have been revised upward marginally over the past 30 days. Shares of CIB have gained 26.4% over the past six months. The stock currently sports a Zacks Rank #1 (Strong Buy). 
The consensus estimate for Banco Macro&#39;s current-year earnings have been revised 29.6% upward over the past 30 days. Over the past three months, shares of BMA have gained 46.5%. The stock currently flaunts a Zacks Rank #1.
<a href="https://www.zacks.com/stock/news/2280215/itau-unibanco-itub-announces-merger-proposal-with-hipercard?cid=CS-BENZ-FT-analyst_blog|company_news_-_finance_sector-2280215">To read this article on Zacks.com click here.</a>

Itau Unibanco Announces Merger Proposal With Hipercard

Fintechs, Argentine banks advance, crypto firms retreat: week's financial roundup

Argentine bank stocks attract Wall Street amid success of Milei's 'shock therapy'

Morgan Stanley double upgraded Banco Macro (BMA) to Overweight from Underweight with a $12.50 price target Policy reforms are steering Argentina to...

Banco Macro upgraded to Overweight from Underweight at Morgan Stanley

Analysts have been eager to weigh in on the Financial sector with new ratings on Bread Financial Holdings (BFH – Research Report) and Banco Macro S...

Analysts Conflicted on These Financial Names: Bread Financial Holdings (BFH) and Banco Macro SA (BMA)

Banco Macro (BMA) is up 8.4%, or $7.84 to $100.82. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial ...

Banco Macro rises 8.4%

BofA upgraded Banco Macro (BMA) to Buy from Neutral with a price target of $107, up from $91. The "impressive" recovery of the Argentine economy an...

Banco Macro upgraded to Buy from Neutral at BofA

Grupo Supervielle: Weaker Capital Ratio May Be An Important Constraint For Higher Share Price Returns Ahead

Upstart, Flagstar sink, while BBAV, BMA climb: week's financials roundup

Total Return Breakouts: Records, Skew, And All New Portfolios For 2025

Argentine banks climb, fintechs retreat in first week of 2025: financials wrap

CIFR

CLSK

FNGU

FUTU

INFY

IREN

KNSL

LMND

MARA

QFIN

RIOT

SMCI

SOFI

SOUN

SOUNW

SPNT

TECL

TSLA

UPST

VOYA

Press Releases

Banco Macro Announces Results for the Fourth Quarter of 2023

Banco Macro S.A. Informs the Market of the Filing of its Annual Report on form 20-F for the Fiscal Year Ended December 31, 2023

Banco Macro Announces Results for the First Quarter of 2024

Banco Macro Announces Results for the Second Quarter of 2024

Banco Macro Announces Results for the Third Quarter of 2024

Lloyds Banking Group Plc American Depositary Shares

Lloyds Banking Group

Mizuho Financial Group, Inc. Sponosred ADR (Japan)

Mizuho Financial Gr

Mitsubishi UFJ Financial Group, Inc. Common Stock

Mitsubishi UFJ Finl Gr

Nu Holdings

NatWest Group plc American Depositary Shares, (each representing two (2) Ordinary Shares)

NatWest Group

PNC Financial Services Group, Inc. (The) Common Stock

PNC Finl Servs Gr

Banco Santander, S.A. Sponsored ADR (Spain)

Banco Santander

Shinhan Financial Group Co Ltd American Depositary Shares

Shinhan Finl Gr

Sumitomo Mitsui Financial Group Inc Unsponsored American Depositary Shares (Japan)

Sumitomo Mitsui Finl Gr

U.S. Bancorp

Woori Financial Group Inc. American Depositary Shares (each representing three (3) shares of Common Stock)

Comments

Banco Macro

Noticias

Últimas noticias sobre Banco Macro (NYSE:BMA) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL